P1379: OPTIMIZATION OF FLUDARABINE PHARMACOKINCETICS TO REDUCE THE RELAPSE INCIDENCE IN AML PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION by T. Thavayogarajah, G. Nair, S. Balabanov, M. G. Manz, D. Müller, U. Schanz

Get full text

S235: A TWO-PART, SINGLE- AND TWO-ARM RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH H... by S. dertschnig, J. finke, D. heim, U. schanz, E. holler, U. holtick, G. socié, T. teshima, C. bucher, J. passweg

Get full text

P379: MUTATIONAL LANDSCAPE IN THERAPY-RELATED ACUTE LYMPHOBLASTIC LEUKEMIA by K. D. Hofer, E. Haralambieva, C. Fritz, M. Roncador, C. Ruetsche, M. Buehler, J. Tchinda, U. Schanz, C. C. Widmer

Get full text

Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience by P Samaras, M Blickenstorfer, SR Haile, D Siciliano, U Petrausch, A Mischo, M Zweifel, H Honegger, U Schanz, G Stüssi, S Bauer, A Knuth, F Stenner-Liewen

Get full text

P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART CO... by G. Basak, C. Peczynski, C. Koenecke, S. Terwel, Y. Cabrerizo, O. Penack, I. Moiseev, H. Schoemans, N. Fegueux, V. Potter, S. Zeerleder, I. Yakoub-Agha, M. Collin, U. Schanz, P. Dreger, D. Blaise, C. Besley, B. Glass, M. Mohty, C. Chabannon, J. Kuball, J. Snowden, A. Sureda, N. Kröger, Z. Peric

Get full text